Skip to content

National wide survey on treatment pattern of locally advanced cervical cancer (LACC) in China

National wide survey on treatment pattern of locally advanced cervical cancer (LACC) in China

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300075052
Enrollment
Unknown
Registered
2023-08-23
Start date
2023-08-31
Completion date
Unknown
Last updated
2023-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

locally advanced cervical cancer

Interventions

Cognitive interview:None
Quantitative online interview:None

Sponsors

Peking Union Medical College Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Must be a board-certified physician specializing in oncology, radiation oncology/therapeutic radiology or gynecology • At least 5 years’ experience in this role after completion of training • Main decision maker of deciding treatment prescription (medication, surgery, and radiation therapy) in the treatment of cervical cancer • Treatment of at least N=30 of patients with cervical cancer in the past 6 months and including at least one patient with locally advanced cervical cancer. • At least 60% of time spent in direct patient care • Provide informed consent

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
General characteristics: age, geographic location, affordability, patient preference, etc.;Disease characteristics: ECGO performance status, FIGO stage, fertility preservation, comorbidities, adherence, etc.;Schedule and regimen, stratified by risk level [FIGO 2014 stage IB2-IIB (node negative disease); IB2-IIB (node positive disease); III-IVA (any node)];Drugs/approaches and dosage of different schedules;Utilization rate of each schedule: number of respondents practice one schedule out of all visited respondents. The most common schedule is the one who gets the highest utilization rate.;Factors related to treatment choice and proportions of each factor;Overall resource utilization associated with treatment and radiotherapy access;Definition of high-risk LACC in clinical practice;

Countries

China

Contacts

Public ContactYang Xiang

Peking Union Medical College Hospital

Xiangy@pumch.cn+86 135 1105 0222

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026